Role of topical tranexamic acid in reducing post-TURP hematuria: a randomized controlled study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262171Keywords:
Antifibrinolytic, Benign prostatic hyperplasia, Postoperative hematuria, Tranexamic acid, TURPAbstract
Background: Postoperative hematuria is a common and clinically significant complication following transurethral resection of the prostate (TURP). Tranexamic acid (TXA), an antifibrinolytic agent, has been investigated to reduce perioperative bleeding in various surgical settings. This study aimed to evaluate the efficacy and safety of topical TXA added to irrigating fluid during monopolar TURP in reducing postoperative hematuria and related outcomes.
Methods: This prospective randomized controlled study was conducted at Dinajpur Medical College Hospital from July 2024 to December 2025. 50 men undergoing monopolar TURP for benign prostatic hyperplasia (BPH) were randomly assigned (1:1) into two groups. The TXA group received 1.5% glycine irrigation with 500 mg/l topical TXA, while the control group received standard 1.5% glycine irrigation. Primary outcomes included duration of gross hematuria and postoperative hemoglobin drop. Secondary outcomes were clot retention, duration of bladder irrigation, catheterization, hospital stay and blood transfusion rate. Data were analyzed using SPSS version 26.
Results: The TXA group demonstrated a significantly shorter duration of gross hematuria (18.6±6.3 vs. 31.4±8.2 hours; p<0.001) and a smaller postoperative hemoglobin reduction (0.9±0.4 vs. 1.6±0.6 g/dl; p<0.001). Fewer patients required bladder irrigation beyond 24 hours (12.0% vs. 36.0%; p=0.04). Differences in clot retention (8.0% vs. 28.0%; p=0.07) and blood transfusion rates (4.0% vs. 16.0%; p=0.16) were not statistically significant.
Conclusions: Topical TXA in irrigating fluid during TURP effectively reduces postoperative hematuria and hemoglobin loss without significant adverse effects, making it a safe and cost-effective adjunct in BPH surgery.
References
Phua TJ. The etiology and pathophysiology genesis of benign prostatic hyperplasia and prostate cancer: a new perspective. Medicines. 2021;8(6):30.
Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urol. 2013;64(1):118-40.
Cornu JN, Herrmann T, Traxer O, Matlaga B. Prevention and management following complications from endourology procedures. European Urol. 2016;2(1):49-59.
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. European Urol. 2010;58(3):384-97.
Eraky AM, Rubenstein SC, Khan A, Mokhtar Y, Gregorich NM. Non-surgical bleeding and transurethral resection of the prostate (TURP) syndrome after TURP surgery: a case report and literature review. Pathophysiology. 2024;31(3):367-75.
Shakur H, Roberts I. Effects of tranexamic acid on death, vascular occlusive events and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled study. In50 Landmark Papers every Trauma Surgeon Should Know. Indian J Neurotraum. 2012;9(1):3-14.
Karkhanei B, Musavi-Bahar SH, Bayat M, Kaseb K, Rezaee H, Moradi A, et al. Safety and efficacy of intraoperative administration of intravenous tranexamic acid in transurethral resection of prostate: A double-blind, randomised, placebo-controlled study. Journal of Clinical Urology. 2020;13(2):125-31.
Colomina MJ, Koo M, Basora M, Pizones J, Mora L, Bagó J. Intraoperative tranexamic acid use in major spine surgery in adults: a multicentre, randomized, placebo-controlled study. BJA: British J Anaesth. 2017;1;118(3):380-90.
Alshryda S, Mason J, Sarda P. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement. J Bone Joint Surg Br. 2013;95(12):1732–8.
Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;20:344.
Pranata FH, Kloping YP, Hidayatullah F, Rahman ZA, Yogiswara N, Rahman IA, et al. The role of tranexamic acid in reducing bleeding during transurethral resection of the prostate: an updated systematic review and meta-analysis of randomized controlled study. Indian J Urol. 2022;38(4):258-67.
He W, Ding T, Niu Z, Hao C, Li C, Xu Z, et al. Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review. Front Endocrinol. 2023;14:1287212.
Aguilera X, Martínez-Zapata MJ, Hinarejos P, Jordán M, Leal J, González JC, et al. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled study. Arch Orthop Trauma Surg. 2015;135(7):1017-25.
Eraky AM, Rubenstein SC, Khan A, Mokhtar Y, Gregorich NM. Non-surgical bleeding and transurethral resection of the prostate (TURP) syndrome after TURP surgery: a case report and literature review. Pathophysiology. 2024;31(3):367-75.
Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, et al. Tranexamic acid in patients undergoing coronary-artery surgery. New England J Med. 2017;376(2):136-48.
Zhong L, Liu Y, Wang Y, Wang H. Effects of local administration of tranexamic acid on reducing postoperative blood loss in surgeries for closed, Sanders III–IV calcaneal fractures: a randomized controlled study. Indian J Orthopaed. 2021;55(2):418-25.
Tawfick A, Mousa W, El-Zhary AF, Saafan AM. Can tranexamic acid in irrigation fluid reduce blood loss during monopolar transurethral resection of the prostate. A randomised controlled study. Arab J Urol. 2022;20(2):94-9.
Draxler DF, Medcalf RL. The fibrinolytic system—more than fibrinolysis?. Transf Med. 2015;29(2):102-9.
Vorobev V, Beloborodov V, Golub I, Frolov A, Kelchevskaya E, Tsoktoev D, et al. Urinary system iatrogenic injuries: problem review. Urologia Int. 2021;105(6):460-9.
Downloads
Published
How to Cite
Issue
Section
